The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670401510) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter designed for use in the peripheral vasculature. With a balloon diameter of 4 mm and a working length of 150 mm, this device combines mechanical dilatation with localized drug delivery using the proprietary TransPax coating technology to support durable luminal gain.
Key Features
- Paclitaxel drug coating: TransPax coating with a low therapeutic drug dose intended to limit downstream particulate loss.
- Balloon dimensions: 4 mm nominal diameter x 150 mm working length.
- Long lesion coverage: 150 mm balloon length suited for treating extended peripheral lesions.
- Low-profile design: Engineered for trackability and crossability through tortuous peripheral anatomy.
- Over-the-wire platform: Compatible with 0.035 inch guidewire systems.
- Sheath compatibility: Refer to manufacturer IFU for minimum introducer sheath size.
Clinical Applications
- Peripheral angioplasty: Percutaneous transluminal angioplasty of stenotic lesions in the peripheral arteries.
- Superficial femoral artery (SFA): Treatment of de novo and restenotic lesions per labeling.
- Popliteal artery: Dilatation of qualifying popliteal lesions per labeling.
- Post-dilatation: May be used following other peripheral interventions where indicated.
- Indications, contraindications and clinical suitability: Refer to the official Instructions for Use.
Product Information
- Brand: Boston Scientific
- Product line: Ranger Drug-Coated Balloon (DCB)
- Device type: Drug-coated PTA balloon catheter
- Drug: Paclitaxel (TransPax coating)
- Balloon diameter: 4 mm
- Balloon length: 150 mm
- Guidewire compatibility: 0.035 inch
- Catheter working length: Not specified in the located sources
- REF/UPN: H74939670401510
- Category: Peripheral Balloon Catheters
- Sterility: Sterile, single-use device
- Storage and handling: Per manufacturer IFU